探索当前的工具心血管风险评估在中东和需要特定区域的模型 - - 一个范围审查
Gamilah Abdulkarem Al-Ezzi1,2, Adliah Mhd Ali1, Mohammed Abdullah Kubas3,4
1Centre for Quality Management of Medicines (QMM), Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Therapeutics and clinical risk management
|October 16, 2025
概括
心血管疾病 (CVD) 风险评估工具在中东地区各不相同. 这次审查发现西方工具和一些国家模型被使用,但需要更多的特定区域的研究.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 心血管疾病 (CVD) 是全球死亡率和残疾的主要原因.
- 有效的初级预防策略依赖于准确的心血管疾病风险评估.
- 中东地区推的心血管疾病风险评估工具的情况尚不清楚.
研究的目的:
- 为中东地区的普通人群推的心血管疾病风险评估工具的识别和总结.
- 审查该地区关于CVD风险预测的现有文献.
主要方法:
- 根据PRISMA-ScR指南进行范围审查.
- 在 Web of Science,Medline 和 Scopus 数据库中进行的搜索.
- 包括2015-2024年的英语文章,重点关注16个中东国家的初级心血管疾病预防.
主要成果:
- 十七篇文章符合纳入标准,涵盖塞浦路斯,伊朗,沙特阿拉伯,卡塔尔,阿联和埃及.
- 推的工具包括西方的模型 (例如,ACC/AHA PCE,Score 2,WHO/ISH EMR,QRISK3,PREDICT).
- 一些国家 (伊朗,沙特阿拉伯,阿联,埃及) 正在开发国家心血管疾病风险工具.
结论:
- 目前关于中东地区心血管疾病风险评估的研究仅限于六个国家.
- 建议混合西方和本地开发的工具.
- 需要进一步的研究来开发或调整该地区针对特定国家心血管疾病风险因素的模型.
相关概念视频
01:23Assessment of the Cardiovascular System I: Subjective Data
752
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
752
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
384
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
384
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
786
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
786
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
811
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
811
01:30Coronary Artery Disease I: Introduction
876
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319